Evidence map›Paper›PMID 38038782›Full record

ArticleCell and tissue banking2024

Remaining microtia tissue as a source for 3D bioprinted elastic cartilage tissue constructs, potential use for surgical microtia reconstruction.

Cristina Velasquillo, Yaaziel Melgarejo-Ramírez, Julieta García-López, Claudia Gutiérrez-Gómez, Hugo Lecona, Maykel González-Torres, José Iván Sánchez-Betancourt, Clemente Ibarra, Sang Jin Lee, James J Yoo

Abstract read
PubMed Publisher
In one paragraph

Article in Cell and tissue banking, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Cristina Velasquillo *Unidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación LGII, Mexico City, Mexico. mvelasquillo@ciencias.unam.mx.ORCID http://orcid.org/0000-0002-0135-5386
Yaaziel Melgarejo-Ramírez *Laboratorio de Biotecnología, Unidad de Gerociencias, Instituto Nacional de Rehabilitación LGII, Mexico City, Mexico. yaazielmr@gmail.com.
Julieta García-LópezUnidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación LGII, Mexico City, Mexico.
Claudia Gutiérrez-GómezDivisión de Cirugía Plástica y Reconstructiva, Hospital General Dr. Manuel Gea González, Mexico City, Mexico.
Hugo LeconaBioterio y Cirugía Experimental, Instituto Nacional de Rehabilitación, Mexico City, Mexico.
Maykel González-TorresLaboratorio de Biotecnología, Unidad de Gerociencias, Instituto Nacional de Rehabilitación LGII, Mexico City, Mexico.
José Iván Sánchez-BetancourtDepartamento de Producción Animal. Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Clemente IbarraUnidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación LGII, Mexico City, Mexico.
Sang Jin LeeWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
James J YooWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Instituto Nacional de Rehabilitación · MXForest Institute · USHospital General Dr. Manuel Gea Gonzalez · MXUniversidad Nacional Autónoma de México · MX

Funding

Armed Forces Institute of Regenerative Medicine X81XWH-08-2-0032Consejo Nacional de Ciencia y Tecnología, México 114359Secretaria de Educación, Ciencia, Tecnología e Innovación (CDMEX) 023/2022
6 · The paper itself

Abstract

The absence of ears in children is a global problem. An implant made of costal cartilage is the standard procedure for ear reconstruction; however, side effects such as pneumothorax, loss of thoracic cage shape, and respiratory complications have been documented. Three-dimensional (3D) printing allows the generation of biocompatible scaffolds that mimic the shape, mechanical strength, and architecture of the native extracellular matrix necessary to promote new elastic cartilage formation. We report the potential use of a 3D-bioprinted poly-ε-caprolactone (3D-PCL) auricle-shaped framework seeded with remaining human microtia chondrocytes for the development of elastic cartilage for autologous microtia ear reconstruction. An in vivo assay of the neo-tissue formed revealed the generation of a 3D pinna-shaped neo-tissue, and confirmed the formation of elastic cartilage by the presence of type II collagen and elastin with histological features and a protein composition consistent with normal elastic cartilage. According to our results, a combination of 3D-PCL auricle frameworks and autologous microtia remnant tissue generates a suitable pinna structure for autologous ear reconstruction.

Indexed as

Congenital MicrotiaElastic CartilagePlastic Surgery ProceduresPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsAnimalsBioprintingChondrocytesHumansPolyesterspolycaprolactonePolyesters3D bioprintingAuricular reconstructionElastic cartilageMicrotiaTissue engineering

Identifiers

PMID38038782
OpenAlexW4389236513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.